Status: Recruiting
Tacrolimus Ophthalmic Solution for the Treatment of Non-infectious Anterior Uveitis
The primary objective of the study is to investigate the safety and tolerability of NOV05 eye drops at two concentrations QID in patients with active non-infectious anterior uveitis.
Participants needed: 20
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Novaliq GmbHUpdated: Jun 15, 2026Locations: 5
Eligibility criteria
Be ≥18 years of age; [+3]
Have severe/serious ocular pathology in the study eye which may preclude study c... [+6]